Awet G. Tecleab, Ph.D.
Affiliations: | 2013 | Medical Sciences | University of South Florida, Tampa, FL, United States |
Area:
Medicine and Surgery, Cell Biology, Molecular Biology, OncologyGoogle:
"Awet Tecleab"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Said M. Sebti | grad student | 2013 | University of South Florida | |
| (Regulation of the Tumor Suppresser p53 and Survivin by Ras and Ral GTPases: Implications for Malignant Transformation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tecleab A, Zhang X, Sebti SM. (2014) Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation. The Journal of Biological Chemistry. 289: 31296-309 |
| Kazi A, Ozcan S, Tecleab A, et al. (2014) Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity Journal of Biological Chemistry. 289: 11906-11915 |
| Tecleab A, Sebti SM. (2013) Depletion of K-Ras promotes proteasome degradation of survivin. Cell Cycle (Georgetown, Tex.). 12: 522-32 |
| Tecleab A, Zhang X, Sebti SM. (2013) Abstract 767: RalGTPase regulation of p53 and its contribution to malignant transformation. Cancer Research. 73: 767-767 |
| Tecleab A, Sebti SM. (2011) Abstract 3844: K-Ras is required for maintaining survivin protein stability in human cancer cells harboring mutant but not wild type K-Ras Cancer Research. 71: 3844-3844 |